Bioactive glass is used as both a bone filler and as a coating on implants, and has been advocated as a potential osteogenic scaffold for tissue engineering. Rat-derived mesenchymal stem cells (MSCs) show elevated levels of alkaline phosphatase activity when grown on 45S5 bioactive glass as compared to standard tissue culture plastic. Similarly, exposure to the dissolution products of 45S5 elevates alkaline phosphatase activity and other osteogenic markers in these cells. We investigated whether human MSCs grown under the same laboratory conditions as rat MSCs would exhibit similar responses. In general, human MSCs produce markedly less alkaline phosphatase activity than rat MSCs, regardless of cell culture conditions, and do not respond to the growth factor BMP-2 in the same way as rat MSCs. In our experiments there was no difference in alkaline phosphatase activity between human MSCs grown on 45S5 bioactive glass or tissue culture plastic, in samples from five different orthopaedic patients, regardless of culture media composition. Neither was there any consistent effect of 45S5 dissolution products on human MSCs from three different donors. These results suggest that the positive effects of bioactive glass on bone growth in human patients are not mediated by accelerated differentiation of mesenchymal stem cells. 
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Differential alkaline phosphatase responses of rat and human bone marrow derived mesenchymal stem cells to 45S5 bioactive glass
Introduction
Bioactive glasses generally form a carbonated apatite layer when immersed in a solution of buffered salts representing the ion concentration of body fluids (simulated body fluids or SBF) [1, 2] . In vitro, bone cells, whether primary or cell-line derived, grow well on bioactive glass and bone matrix production appears to be enhanced when compared with growth on inert glasses or plastics [3, 4] . The effects of bioactive glass on bone cells has been shown to be both substrate [5] and solution mediated [6, 7] . Human osteoblasts exposed only to bioactive glass dissolution products alter their gene activity compared to cells in standard media [8] .
45S5 bioactive glass is a melt-derived glass with composition in weight percent: 45% SiO 2 , 24.5% CaO, 24.5% Na 2 O and 6% P 2 O 5 . It was first developed in the early 1970s [9] and has been shown in multiple studies to have good bone bonding properties [5, 10] . The silica and phosphate compositions of this glass are within the range that allows dissolution and calcium phosphate formation at the surface while maintaining an appropriate rate of degradability. 45S5 bioactive glasses enhance bone apposition on their surface and create a strong bone/implant interface on both particles and coatings [11, 12] . Bioactive glasses, including 45S5 and other compositions are used in clinical procedures such as alveolar ridge augmentation and periodontal defect filling [13] [14] [15] .
It has been suggested that bioactive glasses would make good scaffolds for bone tissue engineering, either alone or in combination with a polymer scaffold [7, 16, 17] . Mesenchymal stem cells (MSCs) are bone marrow-derived
cells of the mesenchymal lineage isolated from whole bone marrow by adhesion to tissue culture plastic [18, 19] . These cells can differentiate into osteoblastic cells, among other mesenchymal lineages. The good bone bonding at the surface of a biomaterial, that is seen when bioactive glasses are implanted in vivo, implies the material has allowed recruitment and/or differentiation of the osteogenic precursors that derive from MSCs. A bioactive glass scaffold seeded with MSCs has been tested in a rat model for its ability to induce bone repair with promising results [20] . In order to exploit the potential of bioactive glass scaffolds for tissue engineering the interactions between the MSCs and the scaffold need to be better understood.
There is evidence that cells derived from bone marrow can be stimulated towards osteogenesis when grown on bioactive glasses [21] [22] [23] . Recently, the dissolution products of 45S5 bioactive glass were shown to enhance the osteogenesis of murine embryonic stem cells [24] . Our previous experiments indicated that rat MSC differentiation is accelerated by growth on 45S5 bioactive glass or exposure to bioactive glass dissolution products [6] . Alkaline phosphatase activity, a marker of osteoblastic differentiation, was shown to be higher than in cells grown on tissue culture plastic. However, it is known that human MSCs respond differently from rodent MSCs to 'osteoinductive' conditions. For instance human MSCs do not react in the same way as rat MSCs to the growth factor BMP-2 [25, 26] . Therefore, in these experiments we exposed human MSCs to the same bioactive glass under identical culture conditions as our previously reported rat MSCs [6] . We examined cell numbers and alkaline phosphatase activity. Our hypothesis was that human MSCs would also show elevated levels of alkaline phosphatase when exposed to 45S5 bioactive glass as a substrate or as dissolution products.
Materials and methods

Bioactive glass
Rods of 45S5 bioactive glass (MO-Sci, Rolla, MO) of 12 mm diameter were cut into 1 mm thick disks on a diamond wheel saw. Disks were cleaned by sonication in acetone and then ethanol. To create a layer of carbonate apatite on the disks, they were immersed in a tris buffered solution (TE) Disks were randomly assigned to rat or human-derived cell experiments and were run over the same time period dependent on availability of cells in no specific order. For all experiments, disks that were pre-treated as above were immersed in 70% ethanol for 30 min then air-dried under UV light in a class II tissue culture cabinet, for sterilization. Sterile disks were placed in basal tissue culture medium, alpha MEM (Invitrogen Life Technologies, Inc., Grand Island, NY), 1% antibiotics (Invitrogen) and 10% fetal bovine serum (FBS; PremiumSelect, Atlanta Biologicals, Norcross, GA) with the addition of 25 mM HEPES buffer (Sigma-Aldrich, St. Louis, MO) for 2 h. This was to allow serum proteins to adsorb to the substrate, a process which was shown to facilitate cell attachment and osteogenesis in MC3T3-E1 osteoblast-like cells [28] .
Isolation and culture of MSCs
Human marrow cells were derived from orthopaedic patients undergoing primary hip replacement by aspiration from the femoral medullary cavity, as previously described [25, 26] . The age, gender and experimental conditions for each donor's cells are specified in Table 1 . Marrow cells were washed twice to remove fatty components, and resuspended in Hanks Balanced Salt Solution (HBSS, Invitrogen). The samples were layered on Ficoll-Paque (Amersham Pharmacia Biotech, Piscataway, NJ) and centrifuged 30 min at 1900 RCF to concentrate nucleated cells at the interface. This fraction was collected, washed once with aMEM media, and resuspended in tissue culture medium. Primary cultures of these cells were established at 5 Â 10 5 cells/cm 2 , and non-adherent cells removed after 3 days. Experiments were carried out after first or second passage.
Rat bone marrow cells were derived from the femora of female Wistar rats, 4-5 weeks old, as described previously [29] . All procedures were approved by the University of Pennsylvania's Institutional Animal Use and Care Committee (IACUC). Briefly, after sacrifice, the ends of the femora were removed and the marrow of the midshaft flushed out with a needle. Marrow was suspended in tissue culture media and plated in a 10 cm tissue culture dished at 1 femur per dish. Non-adherent cells were removed after 3-5 days. Experiments were carried after first or second passage.
Once cells had reached confluence they were removed by 0.25% trypsin in 1 mm tetrasodium EDTA (Invitrogen) and plated on the pre-treated 45S5 bioactive glass disks 1 cm diameter or plastic tissue culture-treated coverslip controls (Thermanox , Corning Inc., Corning, NY) suspended above a layer of cells from the same culture which had been plated in the standard way at the base of a 6-well plate (at 10 Â 10 4 cells/cm 2 ) and 6 ml media added such that the cells on the disk were immersed (Fig. 1) . In preliminary experiments, 45S5 disks pre-treated but not seeded with cells were placed in the inserts. Statistical analysis indicated no effect of cells being present on the disk for the solution-mediated responses.
On the 1st day of culture the medium was exchanged and ascorbate-2-phosphate (Wako Chemicals, Richmond, VA) (100 mg/ml) was added to the fresh medium. Other supplements were added depending on the medium conditions being investigated, these were: 100 ng/ml BMP-2 (Genetics Institute, Cambridge, MA) and 10 À8 M dexamethasone (dex) for rat cells (Sigma) or 10 À7 M dex, for human cells. The media were exchanged on the 4th day. Usually media was replaced with the same supplements as added on day 1, however for some experiments on human cells (Table 1 ) a serum-free media was added on day 4 as developed by Osyczka and Leboy [26] . The serum-containing medium was removed and fresh medium consisting of alpha MEM, 1% antibiotics, ITS+ Premix (containing insulin, transferrin, selenious acid, linoleic acid and bovine serum albumin) (BD Biosciences, Bedford, MA) was added.
Cell staining by MTT
MTT tetrazolium salt staining was used to localize metabolically active cells on the 45S5 bioactive glass surface. Cells were rinsed with PBS and 5 mg/ml MTT (Sigma) in PBS was added, cells were incubated for 1 h at 37 1C then the MTT solution removed and PBS added for viewing under a transmitted light microscope.
Cell number and alkaline phosphatase activity
On day 7 of culture, cells were harvested for total cell number and alkaline phosphatase assays. Cell numbers were assayed either by DNA quantification (CyQUANT cell proliferation assay kit, Molecular Probes, Eugene, OR) or by MTS tetrazolium salt assay of mitochondrial activity (Cell Titer 96 AQueous One Solution Cell Proliferation Assay, Promega, Madison, WI). MTS produces a soluble formazan salt after conversion by mitochondrial dehydrogenase enzymes, as distinct from the insoluble salt produced by MTT. For DNA analysis, cells were trypsinized and a subsample of cell suspension centrifuged, the cell pellet lysed with the CyQUANT lysis buffer and the fluorescent DNA dye added. The resulting solution was transferred to a 96-well plate and DNA assayed fluorometrically. The remaining cells were extracted for the alkaline phosphatase assay. When MTS was used, a 1:10 dilution of MTS was applied to the monolayer of cells in phenol red-free media for 30-60 min, 200 ml of media plus MTS was transferred to a 96-well plate and assayed in a 'Multiskan ascent' plate reader (Thermolabsystems, Franklin, MA). After the respective cell quantification assays the cells were washed twice in HBSS and extracted with 0.15 M Tris, pH 9 with 0.1 mM ZnCl 2 , 0.1 mM MgCl 2 and 1% Triton X-100 for 30 min at 37 1C, followed by overnight storage at 4 1C. A sample of the cell lysate was reacted with p-nitrophenyl phosphate substrate (Sigma) in 1.5 M Tris buffer pH 9 with 1 mM ZnCl 2 and 1 mM MgCl 2 . Phosphatase activity was measured spectrophotometrically at 410 nm with 1 absorbance unit equivalent to 64 nmol of product. Alkaline phosphatase enzyme levels were calculated as nmol p-nitrophenol product per minute normalized to MTS units or mg DNA. There were no differences in relative cell numbers between the two assays so MTS was selected as the favoured assay for the majority of experiments as it required fewer processing steps.
Statistical analysis
Statistics were performed using Minitab TM software. To combine experimental data from multiple experiments data was normalized to an internal control. Paired or two sample t-tests were performed as specified in the results section.
Results
Human MSCs formed a monolayer on the bioactive glass surface and were subjectively less elongated and less confluent than on tissue culture plastic, as seen by MTT staining (Fig. 1) . The MTS assay of metabolic activity also showed that the final number of active cells on bioactive glass was consistently less than that on tissue culture plastic Relative cell number and alkaline phosphatase activity, mean7S.D. for 4 rat and 4 human samples grown on 45S5 bioactive glass, in standard media with ascorbate (asc) plus dexamethasone (dex) supplements, each individual mean was normalized to the tissue culture plastic controls for the respective experiment then data combined. Cell number was slightly but not significantly lower in both rat and human samples. Relative alkaline phosphatase activity was not different for human samples but was 3-fold higher in rats (no significant difference, 1 sample t-test p ¼ 0.085).
for both rat and human cells, but the differences were small and not statistically significant (Fig. 2) . The results presented in Fig. 2 are for cells grown in media containing dexamethasone (dex) and ascorbate (asc) but a similar pattern was seen with all treatments. Alkaline phosphatase activity per cell number in rat MSCs was higher on the 45S5 bioactive glass (Fig. 2) , as reported previously [6] . However, human cell alkaline phosphatase activity did not appear to differ between substrates. Separating the data by animal or human donor indicated that alkaline phosphatase activity levels in rats are generally 10-fold higher than that in humans (Fig. 3) . Within each experiment, rat total alkaline phosphatase activity was significantly higher on bioactive glass than on tissue culture plastic (po0.05). However, human cells gave variable responses and showed no significant overall effect of being grown on 45S5 bioactive glass compared with tissue culture plastic.
Some groups have suggested a synergistic, positive effect of bioactive glasses or hydroxyapatite and BMP-2 on bone cell differentiation [30, 31] . Therefore, we also tested human cell responses under conditions in which BMP-2 was present. Results are shown for one sample (H2) in which four medium conditions were tested: (1) ascorbate alone, (2) ascorbate plus BMP-2, (3) ascorbate plus dex and (4) all 3 supplements. There was no effect of bioactive glass on alkaline phosphatase activity in any medium conditions tested (Fig. 4A) . Note that human MSCs from donor H2 did not respond to BMP-2 with an increase in alkaline phosphatase, as was the case for 90% of human MSC samples tested in our laboratory [26] . However, BMP-2 does increase alkaline phosphatase activity measured on
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JBMT : 5563 There are no media conditions in which alkaline phosphatase activity is higher on bioactive glass than in tissue culture plastic (n ¼ 2). (B) Alkaline phosphatase activity per unit of MTS, mean and S.D. in serum-free conditions for 3 different patients. Alkaline phosphatase activity is much higher in BMP-2 treated samples in serum-free medium compared with controls, the effect of bioactive glass is variable, alkaline phosphatase activity is higher in one patient (H4), n ¼ 2.
day 7 if the medium is exchanged for a defined serum-free medium on day 4. We therefore tested the effect of bioactive glass with and without BMP-2 under these serum-free conditions. As shown in Fig. 4B , bioactive glass did not have a consistent additional effect on human MSCs, although MSCs from one donor (H4) did show an additive effect of BMP+bioactive glass on levels of alkaline phosphatase with serum-free media. Rat MSCs show a significant effect of 45S5 bioactive glass dissolution products on alkaline phosphatase levels [6] . In contrast, as with the substrate effect, cells from different human donors behaved in a variable manner in response to bioactive glass dissolution products. In one sample (H1) alkaline phosphatase activity was modestly higher in cells exposed to 45S5 dissolution products, but in two other donors there was no effect of dissolution products in the medium (Fig. 5 ).
Discussion
Alkaline phosphatase activity as measured by reduction of p-nitophenol phosphate is a common marker of bone cell differentiation. Multiple studies have suggested that alkaline phosphatase activity is enhanced when cells are grown on bioactive glass in both animal-derived cells [3] , human osteoblasts [32] and rat MSCs [6, 21, 33] . It is known that bioactive glass has positive effects on bone apposition in both animal studies [11, 12, 16, 20] and clinical trials [13, 14] . A hypothesis for increased bone formation around bioactive glass implants is that either attachment to the bioactive glass or exposure to its dissolution products enhances osteoblastic differentiation from osteogenic precursors which arise from MSCs. This hypothesis was supported by our finding that alkaline phosphatase activity was enhanced in rat MSCs seeded on 45S5 bioactive glass [6] , as well as other studies with rat marrow-derived cells on various compositions of bioactive glass [21, 33] .
In the current experiments we examined the ability of 45S5 bioactive glass to enhance alkaline phosphatase activity in human MSCs. We obtained highly variable effects of bioactive glass between MSCs derived from four human donors with no consistent effects. While the control surface in these experiments is tissue culture plastic and therefore a idealized cell culture surface (not a bioinert surface), it is interesting to note that rat MSCs consistently produce higher alkaline phosphatase when grown on bioactive glass compared to tissue culture plastic whereas human MSCs do not. In addition, human MSCs grown on tissue culture plastic but exposed to the dissolution products of bioactive glass showed no consistent increase in alkaline phosphatase activity over controls without bioactive glass exposure, despite the reports from our laboratory and others that rat MSCs [6] , mouse embryonic stem cells [24] and human mature osteoblasts [8] show solution-mediated effects of bioactive glasses.
Interestingly, unexpected differences are not unique to the bulk bioactive glass substrates discussed in this paper. Experiments in our laboratory on poly(lactic-co-glycolic acid) (PLGA) foams containing bioactive glass particles showed that rat cells grown on, or in the conditioned medium of, foams including 45S5 bioactive glass particles exhibited higher alkaline phosphatase activity, than in PLGA foams with no inclusions. However, this effect was not seen in human cells, under the same conditions [7] . Yang et al. [16] showed that poly(DL-lactic acid) (PDLLA) foams containing bioactive glass particles were much more effective in increasing alkaline phosphatase activity when they contained only 5 wt% glass compared with 40 wt% glass. A PLGA scaffold coated with 45S5 bioactive glass had no effect on alkaline phosphatase activity or osteocalcin production by human MSCs compared with uncoated scaffolds at 1, 2 or 4 weeks of culture [17] . While it is difficult to compare our results with those of others who have used different composites, pre-treatment and characterization techniques, it is interesting to note that these papers all have in common a low or no alkaline phosphatase response by human MSCs to bioactive glasses.
The apparent lack of response of human MSCs to bioactive glass is unlikely to be mediated by the media composition, as a change in medium composition known to markedly increase the human MSC alkaline phosphatase response to BMP-2 [26] had no significant effect on the lack of response to bioactive glass (Fig. 5) . In this study, we have only examined the alkaline phosphatase response to bioactive glass, because it is a commonly used marker repeatedly found to increase on bone cell differentiation. It is possible that other markers of differentiation could increase independently of alkaline phosphatase in human MSCs. However, we believe this is unlikely because our studies with rat cells showed that mRNA for alkaline phosphatase and other gene level responses (mRNA for osteopontin, osteocalcin and bone sialoprotein) were regulated in exactly the same way in response to 45S5/ 
PLGA composite [7] . In addition, another study of bioactive glass-coated PLGA showed that levels of osteocalcin responded in the same way as the levels of alkaline phosphatase in response to the bioactive glass coating [17] . Leach et al. [17] have suggested that the effects of bioactive glass in vivo may be unrelated to effects on MSCs, proposing that the enhanced bone growth associated with implantation of bioactive glass or bioactive glass-coated materials was a secondary effect of increased vasculogenesis. The basis for their suggestion was the observation that 45S5-coated scaffolds that did not affect alkaline phosphatase activity of human MSCs in vitro, still elicited a marked increase in bone formation in vivo, which was associated with a positive affect on blood vessel recruitment. While we did not test vasculogenesis, our data supports the suggestion that bioactive glass supports bone formation by a more complex mechanism than direct stimulation of MSC differentiation.
It is possible that when testing the effect of bioactive glass on bone cells in vitro a mixed cell population needs to be present to better represent the in vivo environment. For example osteoclastic differentiation and activity (as assayed by tartrate-resistant acidic phosphatase staining) can also increase when osteoclast precursors derived from bone marrow are seeded on bioactive glass [26] [34] . Since osteoclasts and osteoblasts modulate the differentiation of each other, osteoclasts may need to be present for an effect on differentiation to be seen in human cells.
Conclusions
The hypothesis that bioactive glass stimulates bone formation through direct effects on MSC differentiation is not supported by our data on MSCs from five different human donors. While human MSCs proliferated and differentiated as well on bioactive glass as on tissue culture plastic, there was no enhanced production of the bone differentiation marker alkaline phosphatase. This is in contrast to the previously reported osteogenic effects of 45S5 bioactive glass on rat MSCs. While our results do not contradict the usefulness of bioactive glass as an implant material, where a complex mixture of cells and growth factors is present, a more thorough characterization of human MSC responses to bioactive glass in vitro is necessary in order to understand how bioactive glass might be used as a scaffold for in vivo tissue engineering. 
